<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">SCV</journal-id>
<journal-id journal-id-type="hwp">spscv</journal-id>
<journal-id journal-id-type="nlm-ta">Semin Cardiothorac Vasc Anesth</journal-id>
<journal-title>Seminars in Cardiothoracic and Vascular Anesthesia</journal-title>
<issn pub-type="ppub">1089-2532</issn>
<issn pub-type="epub">1940-5596</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1089253211433362</article-id>
<article-id pub-id-type="publisher-id">10.1177_1089253211433362</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Educational Forum</subject>
<subj-group subj-group-type="heading">
<subject>Clinical Challenges</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>End-Stage Pulmonary Disease and Brachial Plexus Regional Anesthesia</article-title>
<subtitle>Their Implications on Perioperative Pulmonary Function</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sanchez</surname><given-names>Maricela</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1089253211433362">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Malhotra</surname><given-names>Nisha</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1089253211433362">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lin</surname><given-names>Ludwig</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-1089253211433362">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1089253211433362"><label>1</label>Columbia University, New York, NY, USA</aff>
<aff id="aff2-1089253211433362"><label>2</label>UCSD, San Diego, CA, USA</aff>
<aff id="aff3-1089253211433362"><label>3</label>Stanford University, San Francisco, CA, USA</aff>
<author-notes>
<corresp id="corresp1-1089253211433362">Ludwig Lin, Stanford University, 875 Indiana St #514, San Francisco, CA 94107, USA Email: <email>ludwigl@sbcglobal.net</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>16</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>64</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The authors present the challenging clinical scenario of managing a patient with end-stage chronic obstructive pulmonary disease requiring anesthesia for a proximal humerus open reduction and internal fixation who likely would have failed to wean from mechanical ventilation if general anesthesia and endotracheal intubation had been chosen as the maintenance technique. They discuss the effects of general and regional anesthesia on respiratory physiology and describe the perioperative implications of severe pulmonary disease. They also review the various brachial plexus block options that could achieve a satisfactory outcome, with the objective of helping guide practitioners to a rational choice of anesthetic techniques when caring for patients with end-stage pulmonary disease.</p>
</abstract>
<kwd-group>
<kwd>analgesia</kwd>
<kwd>critical care</kwd>
<kwd>postoperative complications</kwd>
<kwd>postoperative care</kwd>
<kwd>perioperative mortality</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1089253211433362">
<title>Case Report</title>
<p>A 71-year-old man with metastatic non-small-cell lung cancer presented for a right humerus biopsy and open reduction and internal fixation of a pathological proximal humerus fracture (see <xref ref-type="fig" rid="fig1-1089253211433362">Figure 1</xref>). His past medical history was significant for severe chronic obstructive pulmonary disease (COPD) on home oxygen, a 50-pack year smoking history, prostate cancer status post radiation therapy, and persistent bony pain requiring chronic opioids. His home pain medications included oxycodone/acetaminophen, 8 tablets daily, and a fentanyl patch 75 µg/h.</p>
<fig id="fig1-1089253211433362" position="float">
<label>Figure 1.</label>
<caption>
<p>MRI depicting pathological fracture of the proximal humerus</p>
</caption>
<graphic xlink:href="10.1177_1089253211433362-fig1.tif"/></fig>
<p>On examination, he had clear breath sounds bilaterally with no wheezing, and oxygen saturation of 98% on 2 L/min nasal cannula. Arterial blood gas on room air showed arterial pH of 7.43, pCO<sub>2</sub> of 48.5 mm Hg, pO<sub>2</sub> of 85 mm Hg, and base excess of 7.2. Pulmonary function tests revealed a reduced forced expiratory volume in one second (FEV1) of 1.06 L (36% of predicted) and an FEV1/forced vital capacity (FVC) of 53%. A chest radiograph demonstrated emphysematous changes but no infiltrate.</p>
</sec>
<sec id="section2-1089253211433362">
<title>Background</title>
<p>Patients with severe COPD are at higher risk for mechanical respiratory failure than the general population, making them more likely to require prolonged mechanical ventilation after general endotracheal anesthesia.<sup><xref ref-type="bibr" rid="bibr1-1089253211433362">1</xref></sup> In situations where anesthetic options exist for a particular surgical procedure, regional blocks may be a desirable alternative. However, in the scenario of an upper-extremity surgery, regional techniques that block the phrenic nerve can worsen respiratory mechanics. It is therefore important to be aware of the risks of various brachial plexus techniques when managing patients with severe lung disease to minimize respiratory compromise. This article reviews the implications of pulmonary disease in recovery from anesthesia, discusses the considerations in evaluating pulmonary disease patients for brachial plexus regional anesthesia, and aims to enable the anesthesiologist to use various strategies in optimizing outcomes for patients with severe lung disease.</p>
</sec>
<sec id="section3-1089253211433362">
<title>Risks of General Anesthesia in COPD</title>
<p>The use of general anesthesia involving tracheal intubation in a patient with severe COPD is associated with a high risk of perioperative respiratory complications. Postoperative pulmonary complications (PPCs)—defined as refractory bronchospasm, prolonged intubation, pneumonia, prolonged ICU stay, or death—were found to occur in 37% of patients with COPD undergoing noncardiac surgery under general endotracheal anesthesia. In contrast, PPCs have been reported to occur in 5% to 10% of the general patient population.<sup><xref ref-type="bibr" rid="bibr1-1089253211433362">1</xref></sup> COPD patients may exhibit particular sensitivity to opioids and benzodiazepines because these agents may cause prolonged ventilatory depression that can worsen hypercarbia, hypoxemia, and minute ventilation. A patient with underlying COPD is 7 times more likely than a healthy patient to require reintubation in the immediate postoperative period. Reintubation after planned extubation increases hospital length of stay and is strongly associated with the development of PPCs, increased hospital cost, and late mortality.<sup><xref ref-type="bibr" rid="bibr2-1089253211433362">2</xref></sup></p>
</sec>
<sec id="section4-1089253211433362">
<title>Respiratory Dysfunction in COPD</title>
<p>The source of respiratory dysfunction in COPD is largely a result of inspiratory muscle weakness. The cause of inspiratory muscle weakness has traditionally been attributed to hyperinflation-induced shortening of the diaphragm. However, alterations occur at the cellular level that contribute to loss of diaphragmatic muscle strength early in the course of the disease. A shift in muscle fiber type from type II (high tension and contractility) to type I (fatigue-resistant) fibers results in decreased force generation.</p>
<p>Additionally, oxidative stress and sarcomeric injury leads to further contractile protein wasting. The end result is a decreased maximal inspiratory pressure in patients with COPD compared with healthy controls. Maximal transdiaphragmatic pressures in persons with severe COPD are only 65% of the pressures generated by a healthy individual. The pathological changes that occur at the cellular level are evident early in the course of the disease (Gold Stage I/II), although the patient may be completely asymptomatic.<sup><xref ref-type="bibr" rid="bibr3-1089253211433362">3</xref></sup></p>
</sec>
<sec id="section5-1089253211433362">
<title>Anesthetic Management Strategy</title>
<sec id="section6-1089253211433362">
<title>Preoperative Evaluation</title>
<p>Preoperative evaluation of the patient with documented or suspected COPD is crucial to preempt perioperative pulmonary complications.</p>
<sec id="section7-1089253211433362">
<title>History</title>
<p>A detailed history focused on the presence of dyspnea, cough, sputum production, history of tobacco use, and exercise intolerance can alert the clinician to the severity of pulmonary disease.<sup><xref ref-type="bibr" rid="bibr4-1089253211433362">4</xref></sup> Preoperative elements that are most strongly predictive of PPCs include age &gt;65 years, dyspnea-limited exercise intolerance of 2 blocks or less, and the presence of a chronic productive cough.<sup><xref ref-type="bibr" rid="bibr5-1089253211433362">5</xref>,<xref ref-type="bibr" rid="bibr6-1089253211433362">6</xref></sup> The use of home oxygen therapy is suggestive of severe disease, as it is generally reserved for patients with severe resting hypoxemia (PaO<sub>2</sub> &lt; 60 mm Hg). Oxygen therapy has demonstrated improved exercise capacity and decreased mortality in patients with severe COPD but not in those with mild to moderate disease.<sup><xref ref-type="bibr" rid="bibr7-1089253211433362">7</xref></sup></p>
</sec>
<sec id="section8-1089253211433362">
<title>Physical exam</title>
<p>Findings that should alert the clinician to a greater likelihood of postoperative respiratory compromise include obesity, limb muscle wasting, wheezing or decreased breath sounds on auscultation, and the use of accessory muscles of respiration during normal conversation. Obesity (BMI &gt; 30 kg/m<sup>2</sup>), although not correlated with a higher incidence of surgical mortality, is associated with an increased risk of postoperative atelectasis, which in turn may result in further respiratory complications.<sup><xref ref-type="bibr" rid="bibr8-1089253211433362">8</xref></sup> Limb muscle wasting is an extrapulmonary consequence of COPD and an important prognostic indicator.<sup><xref ref-type="bibr" rid="bibr9-1089253211433362">9</xref></sup> Increased skeletal muscle weakness is associated with decreased exercise capacity, more frequent hospitalizations, and increased mortality.<sup><xref ref-type="bibr" rid="bibr10-1089253211433362">10</xref></sup> The presence of reduced quadriceps muscle strength was found to be a more powerful predictor of mortality in patients with COPD than age, BMI, or FEV1.<sup><xref ref-type="bibr" rid="bibr11-1089253211433362">11</xref></sup></p>
</sec>
</sec>
<sec id="section9-1089253211433362">
<title>Investigations</title>
<sec id="section10-1089253211433362">
<title>Chest X ray</title>
<p>Radiographic evidence classically associated with chronic bronchitis includes flattening of the diaphragm, vertical cardiac silhouette, and hyperlucency at the peripheries of the lung fields. However, abnormalities on chest radiography may be absent or minimal, even in cases of severe COPD.<sup><xref ref-type="bibr" rid="bibr5-1089253211433362">5</xref></sup></p>
</sec>
<sec id="section11-1089253211433362">
<title>Arterial blood gas (ABG)</title>
<p>Chronic hypercapnia, defined as persistently elevated PaCO<sub>2</sub> values &gt;45 mm Hg, is correlated with a higher risk of PPCs or death.<sup><xref ref-type="bibr" rid="bibr8-1089253211433362">8</xref></sup> Hypoxia results from worsening V/Q mismatch and contributes to a decline in clinical status through multiple mechanisms. Chronically hypoxemic COPD patients have accentuated skeletal muscle wasting.<sup><xref ref-type="bibr" rid="bibr10-1089253211433362">10</xref></sup> Higher markers of oxidative stress are evident in COPD patients with chronic hypoxemia; oxidative stress impairs skeletal muscle contractility both at rest and during exercise.<sup><xref ref-type="bibr" rid="bibr12-1089253211433362">12</xref></sup> The diaphragm, composed of 100% skeletal muscle, is implicated in this loss of strength. Additionally, alveolar hypoxia can contribute to the development of pulmonary hypertension in COPD.<sup><xref ref-type="bibr" rid="bibr10-1089253211433362">10</xref></sup></p>
</sec>
<sec id="section12-1089253211433362">
<title>Pulmonary function tests (PFTs)</title>
<p>These are useful in the evaluation of COPD and include spirometry, measurement of lung volumes, and diffusing capacity for carbon monoxide (DLCO).<sup><xref ref-type="bibr" rid="bibr13-1089253211433362">13</xref></sup> The defining pulmonary characteristic of COPD is airflow limitation that is not fully reversible. Airflow limitation is best measured by spirometry and is defined as the fixed ratio of post bronchodilator FEV1/FVC &lt; 0.70. Although a clinical diagnosis of COPD should be considered in a patient with chronic and progressive dyspnea, cough, and sputum production, the gold standard for definitive diagnosis is spirometry.<sup><xref ref-type="bibr" rid="bibr14-1089253211433362">14</xref></sup> Spirometry is also used in the classification of disease severity. The spirometry classification of severity of COPD includes 4 stages of disease: stage I, mild; stage II, moderate; stage III, severe; and stage IV, very severe (see <xref ref-type="table" rid="table1-1089253211433362">Table 1</xref>).</p>
<table-wrap id="table1-1089253211433362" position="float">
<label>Table 1.</label>
<caption>
<p>Spirometric Classification of COPD Severity Based on Postbronchodilator FEV1<sup><xref ref-type="table-fn" rid="table-fn2-1089253211433362">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table1-1089253211433362" xlink:href="10.1177_1089253211433362-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">GOLD Stage</th>
<th align="center">Description</th>
<th align="center">FEV1</th>
</tr>
</thead>
<tbody>
<tr>
<td>I</td>
<td>Mild COPD</td>
<td>FEV1 &gt; 80% predicted</td>
</tr>
<tr>
<td>II</td>
<td>Moderate</td>
<td>50% &lt; FEV1 &lt; 80% predicted</td>
</tr>
<tr>
<td>III</td>
<td>Severe</td>
<td>30% &lt; FEV1 &lt; 50% predicted</td>
</tr>
<tr>
<td>IV</td>
<td>Very severe</td>
<td>FEV1 &lt; 30% predicted or FEV1 &lt; 50% predicted plus chronic respiratory failure</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1089253211433362">
<p>Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second.</p>
</fn>
<fn id="table-fn2-1089253211433362">
<label>a</label>
<p>Adapted from GOLD (Global Initiative for Chronic Obstructive Lung Disease) executive summary.<sup><xref ref-type="bibr" rid="bibr14-1089253211433362">14</xref></sup></p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The dynamic lung volumes (FEV1 and FVC) of any given individual must be compared with reference values from a normal population. A ventilatory defect is presumed if the dynamic lung volumes (FEV1, FVC, or FEV1/FVC ratio) fall out of the reference range. Decreases in FEV1 in COPD are a result of inflammation, fibrosis, and luminal exudates that result in the narrowing of small peripheral airways and can lead to dynamic airway collapse during expiration.<sup><xref ref-type="bibr" rid="bibr14-1089253211433362">14</xref></sup> In restrictive lung disorders, the FEV1/FVC ratio remains normal or high, but there is a reduction in both FEV1 and FVC. A low FVC together with a decreased FEV1/FVC ratio is suggestive of a mixed ventilatory defect in which both obstructive and restrictive components may coexist.<sup><xref ref-type="bibr" rid="bibr6-1089253211433362">6</xref></sup></p>
<p>The test for DLCO measures the ability of the lungs to transfer gas from the inhaled air to the pulmonary vasculature, reflecting the health of the alveolar capillary membrane. A decreased DLCO is indicative of parenchymal lung disease. In severe COPD, decreased gas transfer is caused by parenchymal destruction and may manifest as hypercapnea and/or hypoxemia.<sup><xref ref-type="bibr" rid="bibr15-1089253211433362">15</xref></sup></p>
<p>Although PFTs have been shown to be useful in predicting the likelihood of pulmonary complications and mortality in lung resection surgery, their utility in other types of surgery is not well defined.<sup><xref ref-type="bibr" rid="bibr16-1089253211433362">16</xref></sup> Overall, clinical signs more reliably predict the likelihood of developing postoperative respiratory complications than do chest radiography, arterial blood gas, or pulmonary function tests in isolation.</p>
</sec>
</sec>
</sec>
<sec id="section13-1089253211433362">
<title>The Anesthetic Plan: Choice of Brachial Plexus Block</title>
<sec id="section14-1089253211433362">
<title>Anatomy of the Brachial Plexus</title>
<p>The brachial plexus arises from spinal nerves C5-8 and T1. The plexus begins as 5 nerve roots, unites to form 3 trunks, then continues to subdivide and join to form 6 divisions, 3 cords, and finally 5 main terminal nerves distally. The original 5 nerve roots (C5-T1) emerge from their respective intervertebral foramina and emerge between the anterior scalene and medial scalene muscles. The phrenic nerve is derived from spinal nerves C3-C4-C5 and normally courses anterior to the anterior scalene muscle in close proximity to the brachial plexus nerve roots (see <xref ref-type="fig" rid="fig2-1089253211433362">Figure 2</xref>). The anatomical proximity of the phrenic nerve to the brachial plexus renders the phrenic nerve susceptible to effects of local anesthetic blockade during brachial plexus regional blockade. The effects on the phrenic nerve are variable depending on the selection of regional technique.</p>
<fig id="fig2-1089253211433362" position="float">
<label>Figure 2.</label>
<caption>
<p>Anatomy of the brachial plexus in relation to the anterior and medial scalene muscles and the phrenic nerve (Edmonton Academy of Regional Anesthesia, <ext-link ext-link-type="uri" xlink:href="http://www.nerveblock.ca/page27/files/BIGanatomy-of-the-brachial-plexus.jpg.jpg">http://www.nerveblock.ca/page27/files/BIGanatomy-of-the-brachial-plexus.jpg.jpg</ext-link>)</p>
</caption>
<graphic xlink:href="10.1177_1089253211433362-fig2.tif"/></fig>
</sec>
<sec id="section15-1089253211433362">
<title>Brachial Plexus Blockade Techniques</title>
<sec id="section16-1089253211433362">
<title>Interscalene</title>
<p>The interscalene block targets the roots of the brachial plexus and is most commonly indicated for surgery of the shoulder and upper arm. Sparing of the ulnar nerve is common, so it is often insufficient for surgery of the hand. The block is performed just lateral to the sternocleidomastoid muscle; ultrasound and/or a nerve stimulation technique further guides placement of local anesthetic in the interscalene groove between the anterior and medial scalene muscles. The local anesthetic administered during an interscalene block frequently spreads to affect spinal nerve roots C5, C4, and even C3, the 3 nerve roots that form the phrenic nerve.<sup><xref ref-type="bibr" rid="bibr17-1089253211433362">17</xref></sup> Because of this local anesthetic spread, the interscalene technique is associated with a near 100% rate of phrenic nerve block and ipsilateral hemidiaphragmatic paralysis.<sup><xref ref-type="bibr" rid="bibr1-1089253211433362">1</xref></sup></p>
<p>What is the significance of ipsilateral hemidiaphragmatic paresis on pulmonary function? The loss of diaphragmatic motor strength significantly decreases expiratory respiratory function. Forced vital capacity and forced expiratory volume are reduced approximately 25% in all patients following interscalene regional blockade, independent of the presence of pulmonary disease. Peak expiratory flow rate is also significantly reduced.<sup><xref ref-type="bibr" rid="bibr18-1089253211433362">18</xref></sup> This effect was found to be independent of the type of local anesthetic used.<sup><xref ref-type="bibr" rid="bibr19-1089253211433362">19</xref></sup> Using a lower dose of local anesthetic under ultrasound guidance may lower but not eliminate the effects on respiratory function.<sup><xref ref-type="bibr" rid="bibr20-1089253211433362">20</xref>,<xref ref-type="bibr" rid="bibr21-1089253211433362">21</xref></sup> Thus, an interscalene is not recommended in patients who are unlikely to tolerate hemidiaphragmatic paresis or a 25% reduction in forced vital capacity.<sup><xref ref-type="bibr" rid="bibr18-1089253211433362">18</xref>,<xref ref-type="bibr" rid="bibr22-1089253211433362">22</xref></sup></p>
</sec>
<sec id="section17-1089253211433362">
<title>Supraclavicular</title>
<p>A supraclavicular block targets the brachial plexus at the level of the trunks or divisions. Despite the more distal placement of the local anesthetic, a supraclavicular block is still associated with a high risk of phrenic nerve blockade, occurring in approximately 50% to 67% of all blocks.<sup><xref ref-type="bibr" rid="bibr23-1089253211433362">23</xref>,<xref ref-type="bibr" rid="bibr24-1089253211433362">24</xref></sup> Patients with complete paralysis of the ipsilateral hemidiaphragm as a result of supraclavicular blockade experience significant changes in pulmonary function in both supine and sitting positions.<sup><xref ref-type="bibr" rid="bibr25-1089253211433362">25</xref></sup> The incidence of hemidiaphragmatic paralysis may be reduced if an ultrasound-guided technique is used instead of a nerve-stimulator approach. In one prospective, randomized, observer-blinded controlled trial of 60 patients, the percentage of complete or partial hemidiaphragmatic paresis in patients receiving an ultrasound-guided supraclavicular block was 0% as compared with 53% in those who received a supraclavicular block using nerve stimulation.<sup><xref ref-type="bibr" rid="bibr26-1089253211433362">26</xref></sup></p>
</sec>
<sec id="section18-1089253211433362">
<title>Infraclavicular</title>
<p>An infraclavicular block targets the brachial plexus at the level of the cords. This technique provides excellent blockade of the entire upper extremity and is sometimes referred to as “the spinal of the arm.” However, C5 and C6 nerve roots can be spared, making the technique less appropriate for surgery of the shoulder or very proximal humerus. There is no evidence of change in pulmonary function as measured by forced expiratory volume following infraclavicular brachial plexus blockade.<sup><xref ref-type="bibr" rid="bibr27-1089253211433362">27</xref></sup> Compared with ultrasound-guided supraclavicular block, ultrasound-guided infraclavicular block had a faster onset and superior coverage of the median and ulnar nerves.<sup><xref ref-type="bibr" rid="bibr28-1089253211433362">28</xref></sup> Ultrasound-guided block performance time was similar in both axillary and supraclavicular block techniques.<sup><xref ref-type="bibr" rid="bibr29-1089253211433362">29</xref>,<xref ref-type="bibr" rid="bibr30-1089253211433362">30</xref></sup></p>
</sec>
<sec id="section19-1089253211433362">
<title>Axillary</title>
<p>The axillary block targets the ulnar, median, and radial nerves as they course alongside the axillary artery and vein at the apex of the axilla. This comparatively distal block means that phrenic nerve paralysis is least likely here when compared with all other brachial plexus regional techniques. However, it is not highly reliable for surgical anesthesia at or above the elbow because of possible frequent sparing of the radial and/or musculocutaneous nerve distribution. There is also a higher incidence of inadvertent vessel puncture and intravascular injection of local anesthetic when using the nerve-stimulator technique during axillary blockade.<sup><xref ref-type="bibr" rid="bibr31-1089253211433362">31</xref></sup></p>
</sec>
</sec>
</sec>
<sec id="section20-1089253211433362">
<title>Discussion</title>
<p>Various techniques have been used to measure paradoxical motion of the diaphragm after block on healthy patients: ultrasound with forced sniff maneuver, inductive plethysmography measuring negative abdominal excursion, PFTs, fluoroscopy, and X ray imaging. However, the presence or absence of paradoxical diaphragm motion does not reliably predict the degree of respiratory dysfunction a patient with COPD experiences as a result of intrinsic changes of the diaphragm and altered mechanics of breathing.</p>
<p>Although paradoxical diaphragm movement has been shown to resolve before the sensory block effect terminates, it can have a prolonged effect in a patient with COPD.<sup><xref ref-type="bibr" rid="bibr22-1089253211433362">22</xref></sup></p>
<p>Interscalene and supraclavicular blocks both carry a high risk of hemidiaphragmatic paresis that can precipitate respiratory failure in a patient with severe obstructive pulmonary disease. An axillary block is the upper-extremity regional technique least likely to affect the phrenic nerve, but its utility is limited to the lower arm and hand. An infraclavicular block performed under careful ultrasound guidance carries a very low risk of phrenic nerve blockade and yet offers excellent blockade to much of the upper extremity. Although the infraclavicular block does not guarantee coverage of the entire C5-C6 distribution needed for proximal humerus surgeries, a suprascapular nerve block in addition to an infraclavicular block is an option for surgery involving the proximal humerus.</p>
<p>In this particular patient, intrinsic pulmonary function was so marginal and further complicated by a high opiate dependency which resulted in a baseline respiratory acidosis, that general anesthesia and endotracheal intubation were deemed liable to leave him dependent on postoperative mechanical ventilation. Given the severity of his medical comorbidities, this would likely have been a preterminal event. Therefore, a technique of regional anesthesia providing surgical anesthesia was strongly preferable. An interscalene or supraclavicular block would provide adequate coverage for the proposed operation, but both techniques are associated with a high risk of diaphragmatic hemiparesis. Instead, a continuous infraclavicular nerve catheter was placed under ultrasound guidance. An intercostobrachial block was also performed, and intravenous dexmedetomidine was used for intraoperative sedation. The patient did well, avoiding general anesthesia. He had good postoperative analgesia and was discharged home after his successful palliative humerus open reduction and internal fixation.</p>
<p>As illustrated by his management, the goals in the selection of an appropriate regional technique for the COPD patient undergoing upper-extremity surgery is to both minimize the risk of postoperative respiratory failure as well as provide optimal operative anesthesia and postoperative analgesia. It is important to carefully assess the severity of preexisting pulmonary disease to determine whether the patient would be able to tolerate a potential hemidiaphragmatic blockade because that would influence the type of brachial plexus blockade chosen. At the same time, the surgical site dictates a particular block technique. By familiarizing oneself with the indications and complications of the various brachial plexus nerve regional techniques, the anesthesiologist can successfully manage patients with severe obstructive lung disease having upper-extremity surgery while minimizing postoperative respiratory complications.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1089253211433362">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname><given-names>DH</given-names></name>
<name><surname>Weber</surname><given-names>EC</given-names></name>
<name><surname>Schell</surname><given-names>MJ</given-names></name>
<name><surname>Wong</surname><given-names>AB</given-names></name>
<name><surname>Anderson</surname><given-names>CT</given-names></name>
<name><surname>Barker</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease</article-title>. <source>Anesth Analg</source>. <year>1995</year>;<volume>80</volume>:<fpage>276</fpage>-<lpage>284</lpage>.</citation>
</ref>
<ref id="bibr2-1089253211433362">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ting</surname><given-names>PC</given-names></name>
<name><surname>Chou</surname><given-names>AH</given-names></name>
<name><surname>Yang</surname><given-names>MW</given-names></name>
<name><surname>Ho</surname><given-names>AC</given-names></name>
<name><surname>Chang</surname><given-names>CJ</given-names></name>
<name><surname>Chang</surname><given-names>SC</given-names></name>
</person-group>. <article-title>Postoperative reintubation after planned extubation: a review of 137,866 general anesthetics from 2005 to 2007 in a Medical Center of Taiwan</article-title>. <source>Acta Anaesthesiol Taiwan</source>. <year>2010</year>;<volume>48</volume>:<fpage>167</fpage>-<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr3-1089253211433362">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coen</surname><given-names>AC</given-names></name>
<name><surname>Ottenheijm</surname><given-names>L</given-names></name>
<name><surname>Heunks</surname><given-names>MA</given-names></name>
<name><surname>Dekhuijzen</surname><given-names>R</given-names></name>
</person-group>. <article-title>Diaphragm adaptations in patients with COPD</article-title>. <source>Respir Res</source>. <year>2008</year>;<volume>9</volume>:<fpage>12</fpage>.</citation>
</ref>
<ref id="bibr4-1089253211433362">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bapoje</surname><given-names>SR</given-names></name>
<name><surname>Whitaker</surname><given-names>JF</given-names></name>
<name><surname>Schulz</surname><given-names>T</given-names></name>
<name><surname>Chu</surname><given-names>ES</given-names></name>
<name><surname>Albert</surname><given-names>RK</given-names></name>
</person-group>. <article-title>Preoperative evaluation of the patient with pulmonary disease</article-title>. <source>Chest</source>. <year>2007</year>;<volume>132</volume>:<fpage>1637</fpage>-<lpage>1645</lpage>.</citation>
</ref>
<ref id="bibr5-1089253211433362">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McAlister</surname><given-names>FA</given-names></name>
<name><surname>Khan</surname><given-names>NA</given-names></name>
<name><surname>Straus</surname><given-names>SE</given-names></name><etal/>
</person-group>. <article-title>Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2003</year>;<volume>167</volume>:<fpage>741</fpage>-<lpage>744</lpage>.</citation>
</ref>
<ref id="bibr6-1089253211433362">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pierce</surname><given-names>R</given-names></name>
</person-group>. <article-title>Spirometry: an essential clinical measurement</article-title>. <source>Aust Fam Physician</source>. <year>2005</year>;<volume>34</volume>:<fpage>535</fpage>-<lpage>539</lpage>.</citation>
</ref>
<ref id="bibr7-1089253211433362">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stoller</surname><given-names>JK</given-names></name>
<name><surname>Panos</surname><given-names>RJ</given-names></name>
<name><surname>Krachman</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial</article-title>. <source>Chest</source>. <year>2010</year>;<volume>138</volume>:<fpage>179</fpage>-<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr8-1089253211433362">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doyle</surname><given-names>R</given-names></name>
</person-group>. <article-title>Assessing and modifying the risk of postoperative pulmonary complications</article-title>. <source>Chest</source>. <year>1999</year>;<volume>15</volume>:<fpage>77S</fpage>-<lpage>81S</lpage>.</citation>
</ref>
<ref id="bibr9-1089253211433362">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hopkinson</surname><given-names>NS</given-names></name>
<name><surname>Tennant</surname><given-names>RC</given-names></name>
<name><surname>Dayer</surname><given-names>MJ</given-names></name><etal/>
</person-group>. <article-title>A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease</article-title>. <source>Respir Res</source>. <year>2007</year>;<volume>8</volume>:<fpage>25</fpage>.</citation>
</ref>
<ref id="bibr10-1089253211433362">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kent</surname><given-names>BD</given-names></name>
<name><surname>Mitchell</surname><given-names>P</given-names></name>
<name><surname>McNicholas</surname><given-names>WT</given-names></name>
</person-group>. <article-title>Hypoxemia in patients with COPD: cause, effects, and disease progression</article-title>. <source>Int J Chron Obstruct Pulmon Dis</source>. <year>2011</year>;<volume>6</volume>:<fpage>99</fpage>-<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr11-1089253211433362">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Swallow</surname><given-names>EB</given-names></name>
<name><surname>Reyes</surname><given-names>D</given-names></name>
<name><surname>Hopkinson</surname><given-names>NS</given-names></name><etal/>
</person-group>. <article-title>Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease</article-title>. <source>Thorax</source>. <year>2007</year>;<volume>62</volume>:<fpage>115</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr12-1089253211433362">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koechlin</surname><given-names>C</given-names></name>
<name><surname>Maltais</surname><given-names>F</given-names></name>
<name><surname>Saey</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease</article-title>. <source>Thorax</source>. <year>2005</year>;<volume>60</volume>:<fpage>834</fpage>-<lpage>841</lpage>.</citation>
</ref>
<ref id="bibr13-1089253211433362">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crapo</surname><given-names>RO</given-names></name>
</person-group>. <article-title>Pulmonary-function testing</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>331</volume>:<fpage>25</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr14-1089253211433362">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rabe</surname><given-names>K</given-names></name>
<name><surname>Hurd</surname><given-names>S</given-names></name>
<name><surname>Anzueto</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2007</year>;<volume>176</volume>:<fpage>532</fpage>-<lpage>555</lpage>.</citation>
</ref>
<ref id="bibr15-1089253211433362">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crapo</surname><given-names>RO</given-names></name>
<name><surname>Jensen</surname><given-names>RL</given-names></name>
<name><surname>Wanger</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Single-breath carbon monoxide diffusing capacity</article-title>. <source>Clin Chest Med</source>. <year>2001</year>;<volume>22</volume>:<fpage>637</fpage>-<lpage>649</lpage>.</citation>
</ref>
<ref id="bibr16-1089253211433362">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferguson</surname><given-names>MK</given-names></name>
</person-group>. <article-title>Preoperative assessment of pulmonary risk</article-title>. <source>Chest</source>. <year>1999</year>;<volume>15</volume>:58S-63S.</citation>
</ref>
<ref id="bibr17-1089253211433362">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Winnie</surname><given-names>AP</given-names></name>
</person-group>. <article-title>Intersalene brachial plexus block</article-title>. <source>Anesth Analg</source>. <year>1970</year>;<volume>49</volume>:<fpage>455</fpage>-<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr18-1089253211433362">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pere</surname><given-names>P</given-names></name>
<name><surname>Pitkänen</surname><given-names>M</given-names></name>
<name><surname>Rosenberg</surname><given-names>PH</given-names></name><etal/>
</person-group>. <article-title>Effect of continuous interscalene brachial plexus block on diaphragm motion and on ventilatory function</article-title>. <source>Acta Anaesthesiol Scand</source>. <year>1992</year>;<volume>36</volume>:<fpage>53</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr19-1089253211433362">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hortense</surname><given-names>A</given-names></name>
<name><surname>Perez</surname><given-names>MV</given-names></name>
<name><surname>Amaral</surname><given-names>JL</given-names></name>
<name><surname>Oshiro</surname><given-names>AC</given-names></name>
<name><surname>Rossetti</surname><given-names>HB</given-names></name>
</person-group>. <article-title>Interscalene brachial plexus block: effects on pulmonary function</article-title>. <source>Rev Bras Anestesiol</source>. <year>2010</year>;<volume>60</volume>:<fpage>130</fpage>-<lpage>137</lpage>,74-78.</citation>
</ref>
<ref id="bibr20-1089253211433362">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Kaisy</surname><given-names>AA</given-names></name>
<name><surname>Chan</surname><given-names>VW</given-names></name>
<name><surname>Perlas</surname><given-names>A</given-names></name>
</person-group>. <article-title>Respiratory effects of low-dose bupivacaine interscalene block</article-title>. <source>Br J Anaesth</source>. <year>1999</year>;<volume>82</volume>:<fpage>217</fpage>-<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr21-1089253211433362">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Renes</surname><given-names>SH</given-names></name>
<name><surname>Rettig</surname><given-names>HC</given-names></name>
<name><surname>Gielen</surname><given-names>MJ</given-names></name>
<name><surname>Wilder-Smith</surname><given-names>OH</given-names></name>
<name><surname>van Geffen</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>Ultrasound-guided low-dose interscalene brachial plexus block reduces the incidence of hemidiaphragmatic paresis</article-title>. <source>Reg Anesth Pain Med</source>. <year>2009</year>;<volume>34</volume>:<fpage>498</fpage>-<lpage>502</lpage>.</citation>
</ref>
<ref id="bibr22-1089253211433362">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Urmey</surname><given-names>WF</given-names></name>
<name><surname>McDonald</surname><given-names>M</given-names></name>
</person-group>. <article-title>Hemidiaphragmatic paresis during interscalene brachial plexus block: effects on pulmonary function and chest wall mechanics</article-title>. <source>Anesth Analg</source>. <year>1992</year>;<volume>74</volume>:<fpage>352</fpage>-<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr23-1089253211433362">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neal</surname><given-names>JM</given-names></name>
<name><surname>Moore</surname><given-names>JM</given-names></name>
<name><surname>Kopacz</surname><given-names>DJ</given-names></name>
<name><surname>Liu</surname><given-names>SS</given-names></name>
<name><surname>Kramer</surname><given-names>DJ</given-names></name>
<name><surname>Plorde</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Quantitative analysis of respiratory, motor, and sensory function after supraclavicular block</article-title>. <source>Anesth Analg</source>. <year>1998</year>;<volume>86</volume>:<fpage>1239</fpage>-<lpage>1244</lpage>.</citation>
</ref>
<ref id="bibr24-1089253211433362">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knoblanche</surname><given-names>GE</given-names></name>
</person-group>. <article-title>The incidence and aetiology of phrenic nerve blockade associated with supraclavicular brachial plexus block</article-title>. <source>Anaesth Intensive Care</source>. <year>1979</year>;<volume>7</volume>:<fpage>346</fpage>-<lpage>349</lpage>.</citation>
</ref>
<ref id="bibr25-1089253211433362">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mak</surname><given-names>PHK</given-names></name>
<name><surname>Irwin</surname><given-names>MG</given-names></name>
<name><surname>Ooi</surname><given-names>CGC</given-names></name>
<name><surname>Chow</surname><given-names>BFM</given-names></name>
</person-group>. <article-title>Incidence of diaphragmatic paralysis following supraclavicular brachial plexus block and its effect on pulmonary function</article-title>. <source>Anaesthesia</source>. <year>2001</year>;<volume>56</volume>:<fpage>352</fpage>-<lpage>356</lpage>.</citation>
</ref>
<ref id="bibr26-1089253211433362">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Renes</surname><given-names>SH</given-names></name>
<name><surname>Spoormans</surname><given-names>HH</given-names></name>
<name><surname>Gielen</surname><given-names>MJ</given-names></name>
<name><surname>Rettig</surname><given-names>HC</given-names></name>
<name><surname>van Geffen</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>Hemidiaphragmatic paresis can be avoided in ultrasound-guided supraclavicular brachial plexus block</article-title>. <source>Reg Anesth Pain Med</source>. <year>2009</year>;<volume>34</volume>:<fpage>595</fpage>-<lpage>599</lpage>.</citation>
</ref>
<ref id="bibr27-1089253211433362">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodríguez</surname><given-names>J</given-names></name>
<name><surname>Bárcena</surname><given-names>M</given-names></name>
<name><surname>Rodríguez</surname><given-names>V</given-names></name>
<name><surname>Aneiros</surname><given-names>F</given-names></name>
<name><surname>Alvarez</surname><given-names>J</given-names></name>
</person-group>. <article-title>Infraclavicular brachial plexus block effects on respiratory function and extent of the block</article-title>. <source>Reg Anesth Pain Med</source>. <year>1998</year>;<volume>23</volume>:<fpage>564</fpage>-<lpage>568</lpage>.</citation>
</ref>
<ref id="bibr28-1089253211433362">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koscielniak-Nielsen</surname><given-names>ZJ</given-names></name>
<name><surname>Frederiksen</surname><given-names>BS</given-names></name>
<name><surname>Rasmussen</surname><given-names>H</given-names></name>
<name><surname>Hesselbjerg</surname><given-names>L</given-names></name>
</person-group>. <article-title>A comparison of ultrasound-guided supraclavicular and infraclavicular blocks for upper extremity surgery</article-title>. <source>Acta Anaesthesiol Scand</source>. <year>2009</year>;<volume>53</volume>:<fpage>620</fpage>-<lpage>626</lpage>.</citation>
</ref>
<ref id="bibr29-1089253211433362">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tran de</surname><given-names>QH</given-names></name>
<name><surname>Russo</surname><given-names>G</given-names></name>
<name><surname>Muñoz</surname><given-names>L</given-names></name>
<name><surname>Zaouter</surname><given-names>C</given-names></name>
<name><surname>Finlayson</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>A prospective, randomized comparison between ultrasound-guided supraclavicular, infraclavicular, and axillary brachial plexus blocks</article-title>. <source>Reg Anesth Pain Med</source>. <year>2009</year>;<volume>34</volume>:<fpage>366</fpage>-<lpage>371</lpage>.</citation>
</ref>
<ref id="bibr30-1089253211433362">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arcand</surname><given-names>G</given-names></name>
<name><surname>Williams</surname><given-names>SR</given-names></name>
<name><surname>Chouinard</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Ultrasound-guided infraclavicular versus supraclavicular block</article-title>. <source>Anesth Analg</source>. <year>2005</year>;<volume>101</volume>:<fpage>886</fpage>-<lpage>890</lpage>.</citation>
</ref>
<ref id="bibr31-1089253211433362">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ertug</surname><given-names>Z</given-names></name>
<name><surname>Yegin</surname><given-names>A</given-names></name>
<name><surname>Ertem</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Comparison of two different techniques for brachial plexus block: infraclavicular versus axillary technique</article-title>. <source>Acta Anaesthesiol Scand</source>. <year>2005</year>;<volume>49</volume>:<fpage>1035</fpage>-<lpage>1039</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>